Intelligent Bio Solutions

Intelligent Bio Solutions Net Tangible Assets

The Net Tangible Assets of Intelligent Bio Solutions (INBS) as of Oct 21, 2026 is 5.51 M USD. In the previous year, Net Tangible Assets was -794,164.00 USD — a change of -793.92% (higher).

Net Tangible Assets

5.51 MUSD

YoY

-793.92%

Last updated:

Net Tangible Assets of Intelligent Bio Solutions is 2026 5.51 M USD. Net Tangible Assets of Intelligent Bio Solutions was 2025 -794,164.00 USD. It decreases by -793.92% higher compared to the previous year.

The Intelligent Bio Solutions Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2019
-4.62 M USD
Jan 1, 2020
-5.19 M USD
Jan 1, 2021
15.06 M USD
Jan 1, 2022
6.55 M USD
Jan 1, 2023
-1.46 M USD
Jan 1, 2024
3.96 M USD
Jan 1, 2025
-794,164.00 USD
Jan 1, 2026
5.51 M USD
The Intelligent Bio Solutions Net Tangible Assets history
YEARNet Tangible AssetsYoY
5.51 MUSD-793.92%
-794,164.00USD-120.07%
3.96 MUSD-371.79%
-1.46 MUSD-122.24%
6.55 MUSD-56.53%
15.06 MUSD-390.33%
-5.19 MUSD+12.38%
-4.62 MUSD+5.48%
-4.38 MUSD-26.00%
-5.91 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intelligent Bio Solutions Stock analysis

What does Intelligent Bio Solutions do? Intelligent Bio Solutions, Inc. generates revenue through its Commercially available Intelligent Fingerprinting Products (IFPG) segment, which includes a portable drug screening system analyzing fingerprint sweat via a one-time cartridge and handheld reader. The company also develops diagnostic tests under the Development Stage Saliva Glucose Biosensor Platform (SGBP), targeting diabetic patients with a non-invasive saliva glucose biosensor (SGB) intended to replace finger-prick blood monitoring. Its biosensor platform supports multiple biological analyte detection for point-of-care diagnostic tests (POCT) in clinical chemistry, immunology, tumor markers, allergens, and endocrinology. The firm serves primary health practitioners and patients seeking non-invasive monitoring solutions. The company's product portfolio features the IFPG segment's portable drug screening system, which is sold to healthcare providers and law enforcement agencies for rapid drug testing. The SGBP segment focuses on developing the Saliva Glucose Biosensor (SGB), a point-of-care diagnostic test expected to address the needs of diabetic patients requiring frequent glucose monitoring without invasive procedures. The biosensor platform enables detection of multiple analytes, expanding the company's offerings in clinical chemistry and related diagnostic fields. Intelligent Bio Solutions, Inc. targets primary health practitioners and patients as key segments for its non-invasive diagnostic solutions. The IFPG segment's portable drug screening system is designed for use in clinical and law enforcement settings, while the SGBP segment's Saliva Glucose Biosensor aims to provide a convenient alternative to traditional blood glucose monitoring for diabetic patients. The company's development stage products focus on replacing invasive methods with real-time, non-invasive monitoring technologies. Intelligent Bio Solutions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intelligent Bio Solutions stock

Net Tangible Assets of Intelligent Bio Solutions is 5.51 M USD in 2026.

Net Tangible Assets of Intelligent Bio Solutions changed from -794,164.00 USD to 5.51 M USD, representing a -793.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Intelligent Bio Solutions since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Intelligent Bio Solutions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Intelligent Bio Solutions

All Key Metrics — Intelligent Bio Solutions